Author Question: Jean finds her closeness to her client Julie very rewarding, and for several weeks her supervisor ... (Read 102 times)

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
Jean finds her closeness to her client Julie very rewarding, and for several weeks her
  supervisor has enjoyed hearing about her success in establishing a strong bond.
  What question should the supervisor's supervisor raise in this situation?
 
  A. What progress has Julie made recently?
  B. How did Jean gain Julie's trust?
  C. Have your other clinicians learned to bond with clients?
  D. What did you do to develop Jean's empathy with Julie?

Question 2

Amy's anxiety is characteristic of a Stage One clinician. What other trait of a Stage
  One clinician does she show?
 
  A. high reactivity to her clients
  B. focusing on patterns among her cases
  C. comfort with experiential exercises
  D. need for emotional closure



aruss1303

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

A

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library